TCG Crossover Management

TCG Crossover Management as of March 31, 2026

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 49 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abivax Sa American Depositary Shares Adrs (ABVX) 20.6 $722M 6.5M 111.35
Cg Oncology Comm (CGON) 7.1 $248M 3.7M 67.68
Tango Therapeutics Comm (TNGX) 6.3 $220M 11M 20.92
Cogent Biosciences Comm (COGT) 5.4 $190M 4.9M 38.49
Centessa Pharmaceuticals Adrs (CNTA) 4.9 $170M 4.3M 39.72
Dianthus Therapeutics Comm (DNTH) 4.0 $141M 1.7M 83.92
Tyra Biosciences Comm (TYRA) 3.6 $124M 3.2M 38.30
Immunovant Comm (IMVT) 3.2 $111M 4.5M 24.84
Biocryst Pharmaceuticals Comm (BCRX) 3.0 $105M 11M 9.52
Mirum Pharmaceuticals Comm (MIRM) 2.8 $98M 1.1M 92.38
Vor Biopharma Comm (VOR) 2.8 $97M 5.7M 17.01
Spyre Therapeutics Comm (SYRE) 2.7 $96M 1.9M 50.44
Amylyx Pharmaceuticals Comm (AMLX) 2.5 $87M 6.2M 13.90
Disc Medicine Comm (IRON) 2.5 $86M 1.3M 63.94
Dyne Therapeutics Comm (DYN) 2.4 $84M 4.6M 18.13
Monte Rosa Therapeutics Comm (GLUE) 2.2 $76M 4.6M 16.45
Savara Comm (SVRA) 1.9 $68M 12M 5.46
Revolution Medicines Comm (RVMD) 1.6 $56M 577k 97.25
Kodiak Sciences Comm (KOD) 1.6 $55M 1.4M 38.12
Lb Pharmaceuticals Comm (LBRX) 1.3 $45M 1.8M 24.62
Surrozen Comm (SRZN) 1.2 $43M 1.5M 29.13
Adc Therapeutics Sa Comm (ADCT) 1.2 $43M 11M 3.75
Relay Therapeutics Comm (RLAY) 1.2 $43M 4.3M 9.95
Fulcrum Therapeutics Comm (FULC) 1.2 $40M 5.3M 7.67
Biohaven Comm (BHVN) 1.1 $39M 4.6M 8.46
Century Therapeutics Comm (IPSC) 1.1 $39M 18M 2.20
Tectonic Therapeutic Comm (TECX) 1.1 $37M 1.2M 30.91
Perspective Therapeutics Comm (CATX) 0.9 $33M 7.9M 4.17
Xencor Comm (XNCR) 0.8 $30M 2.5M 12.06
Entrada Therapeutics Comm (TRDA) 0.8 $29M 2.3M 12.62
Alx Oncology Holdings Comm (ALXO) 0.7 $26M 13M 2.00
Arvinas Holding Comm (ARVN) 0.7 $25M 2.4M 10.60
Janux Therapeutics Comm (JANX) 0.7 $25M 1.8M 13.90
Agomab Therapeutics Nv Adrs 0.6 $22M 2.1M 10.49
Alector Comm (ALEC) 0.6 $22M 10M 2.15
Mbx Biosciences Comm (MBX) 0.6 $19M 650k 29.85
Silence Therapeutics Adrs (SLN) 0.5 $16M 3.0M 5.27
Liquidia Technologies Comm (LQDA) 0.4 $15M 403k 37.74
Ocular Therapeutix Comm (OCUL) 0.4 $14M 1.6M 8.47
Avalo Therapeutics Comm (AVTX) 0.3 $11M 738k 14.93
Urogen Pharma Comm (URGN) 0.2 $7.3M 405k 17.98
Monopar Therapeutics Comm (MNPR) 0.2 $7.2M 132k 54.79
Context Therapeutics Comm (CNTX) 0.2 $7.0M 2.7M 2.62
Structure Therapeutics Adrs (GPCR) 0.2 $6.8M 140k 48.20
Cullinan Therapeutics Comm (CGEM) 0.2 $5.8M 407k 14.21
Korro Bio Comm (KRRO) 0.1 $4.7M 416k 11.32
Leonabio Comm (LONA) 0.1 $4.7M 464k 10.05
Upstream Bio Comm (UPB) 0.0 $1.6M 181k 9.00
Vistagen Therapeutics Comm (VTGN) 0.0 $1.5M 2.7M 0.57